Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Elham Sajjadi"'
Autor:
Mariia Ivanova, Carlo Pescia, Dario Trapani, Konstantinos Venetis, Chiara Frascarelli, Eltjona Mane, Giulia Cursano, Elham Sajjadi, Cristian Scatena, Bruna Cerbelli, Giulia d’Amati, Francesca Maria Porta, Elena Guerini-Rocco, Carmen Criscitiello, Giuseppe Curigliano, Nicola Fusco
Publikováno v:
Cancers, Vol 16, Iss 11, p 1981 (2024)
Effective risk assessment in early breast cancer is essential for informed clinical decision-making, yet consensus on defining risk categories remains challenging. This paper explores evolving approaches in risk stratification, encompassing histopath
Externí odkaz:
https://doaj.org/article/7a6001d5bd6440e38dfc0e2e13148902
Autor:
Konstantinos Venetis, Elham Sajjadi, Mariia Ivanova, Silvia Andaloro, Simona Pessina, Chiara Zanetti, Alberto Ranghiero, Gabriele Citelli, Chiara Rossi, Marco Lucioni, Umberto Malapelle, Fabio Pagni, Massimo Barberis, Elena Guerini‐Rocco, Giuseppe Viale, Nicola Fusco
Publikováno v:
Cancer Medicine, Vol 12, Iss 9, Pp 10725-10737 (2023)
Abstract Mucoepidermoid carcinoma (MEC) of the breast is an extremely rare salivary gland‐type tumor characterized by epidermoid, basaloid, intermediate, and/or mucinous cells arranged in solid and cystic patterns. Despite their triple‐negative p
Externí odkaz:
https://doaj.org/article/6d9a91c4d8154198a8750324f48d632e
Autor:
Elham Sajjadi, Konstantinos Venetis, Mariia Ivanova, Marianna Noale, Concetta Blundo, Eugenia Di Loreto, Giovanna Scarfone, Stefano Ferrero, Stefania Maggi, Paolo Veronesi, Viviana E. Galimberti, Giuseppe Viale, Fedro A. Peccatori, Nicola Fusco, Elena Guerini-Rocco
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundBreast cancer during pregnancy (PrBC) is a rare condition known for its aggressive clinical behavior. The presence of tumor-infiltrating lymphocytes (TILs) has been shown to have a significant impact on the prognosis of these patients. Desp
Externí odkaz:
https://doaj.org/article/5f479192c9ee4cc7b05e700cf3fcb210
Autor:
Elham Sajjadi, Elena Guerini-Rocco, Elisa De Camilli, Oriana Pala, Giovanni Mazzarol, Konstantinos Venetis, Mariia Ivanova, Nicola Fusco
Publikováno v:
Frontiers in Molecular Biosciences, Vol 10 (2023)
The introduction of novel anti-HER2 antibody-drug conjugates (ADC) for the treatment of HER2-low breast cancers has transformed the traditional dichotomy of HER2 status to an expanded spectrum. However, the identification of HER2-low (i.e., immunohis
Externí odkaz:
https://doaj.org/article/74a5081e0670443d91e62b68696a9dd0
Autor:
Elham Sajjadi, Konstantinos Venetis, Roberto Piciotti, Donatella Gambini, Concetta Blundo, Letterio Runza, Stefano Ferrero, Elena Guerini-Rocco, Nicola Fusco
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background Phosphatase and tensin homolog (PTEN) loss is associated with tumorigenesis, tumor progression, and therapy resistance in breast cancer. However, the clinical value of PTEN as a biomarker in these patients is controversial. We sou
Externí odkaz:
https://doaj.org/article/fe7008ea3e234d128db2c42c31ca8e8c
Autor:
Elham Sajjadi, Gabriella Gaudioso, Andrea Terrasi, Francesca Boggio, Konstantinos Venetis, Mariia Ivanova, Letizia Bertolasi, Gianluca Lopez, Letterio Runza, Alice Premoli, Daniele Lorenzini, Elena Guerini-Rocco, Stefano Ferrero, Valentina Vaira, Nicola Fusco
Publikováno v:
Frontiers in Molecular Biosciences, Vol 9 (2022)
Background: Breast cancer with osteoclast-like stromal giant cells (OSGC) is an exceedingly rare morphological pattern of invasive breast carcinoma. The tumor immune microenvironment (TIME) of these tumors is populated by OSGC, which resemble osteocl
Externí odkaz:
https://doaj.org/article/e7b1cfe04bef4417850659524f80aa39
Autor:
Francesca Maria Porta, Elham Sajjadi, Konstantinos Venetis, Chiara Frascarelli, Giulia Cursano, Elena Guerini-Rocco, Nicola Fusco, Mariia Ivanova
Publikováno v:
Journal of Personalized Medicine, Vol 13, Iss 7, p 1176 (2023)
Triple-negative breast cancer (TNBC) poses a significant challenge in terms of prognosis and disease recurrence. The limited treatment options and the development of resistance to chemotherapy make it particularly difficult to manage these patients.
Externí odkaz:
https://doaj.org/article/e6f16e14abc74325bec07c19a1441263
Autor:
Mariia Ivanova, Francesca Maria Porta, Federica Giugliano, Chiara Frascarelli, Elham Sajjadi, Konstantinos Venetis, Giulia Cursano, Giovanni Mazzarol, Elena Guerini-Rocco, Giuseppe Curigliano, Carmen Criscitiello, Nicola Fusco
Publikováno v:
Genes, Vol 14, Iss 6, p 1160 (2023)
Breast cancer is the most frequently diagnosed malignancy worldwide and the leading cause of cancer-related death among women. Brain metastases are a primary contributor to mortality, as they often go undetected until late stages due to their dormant
Externí odkaz:
https://doaj.org/article/78562345567c4e0c8343e057dd30dd04
Autor:
Elham Sajjadi, Konstantinos Venetis, Roberto Piciotti, Marco Invernizzi, Elena Guerini-Rocco, Svasti Haricharan, Nicola Fusco
Publikováno v:
Cancer Cell International, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract The clinical outcome of patients with a diagnosis of hormone receptor (HR)+ breast cancer has improved remarkably since the arrival of endocrine therapy. Yet, resistance to standard treatments is a major clinical challenge for breast cancer
Externí odkaz:
https://doaj.org/article/a3ee48279ec747ff8d2483301e7d8db3
Publikováno v:
Journal of Molecular Pathology, Vol 2, Iss 2, Pp 93-100 (2021)
The mismatch repair (MMR) system has a key role in supporting the DNA polymerase proofreading function and in maintaining genome stability. Alterations in the MMR genes are driving events of tumorigenesis, tumor progression, and resistance to therapy
Externí odkaz:
https://doaj.org/article/3ede9e8ec6874ebea65f75d04880d32c